Envista Holdings Co. (NYSE:NVST) Shares Bought by M&T Bank Corp

M&T Bank Corp grew its position in Envista Holdings Co. (NYSE:NVST) by 42.9% in the third quarter, HoldingsChannel reports. The fund owned 15,945 shares of the company’s stock after acquiring an additional 4,787 shares during the quarter. M&T Bank Corp’s holdings in Envista were worth $315,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. GAMMA Investing LLC increased its stake in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after purchasing an additional 726 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Envista by 50.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after buying an additional 728 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Envista by 2.3% during the 2nd quarter. Victory Capital Management Inc. now owns 36,021 shares of the company’s stock worth $599,000 after buying an additional 800 shares during the period. Blue Trust Inc. lifted its position in shares of Envista by 69.7% during the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after buying an additional 804 shares in the last quarter. Finally, Huntington National Bank grew its stake in Envista by 97.8% in the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after acquiring an additional 949 shares during the period.

Analyst Ratings Changes

A number of equities analysts have weighed in on NVST shares. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and upped their price objective for the stock from $16.00 to $23.00 in a research report on Thursday, October 31st. Robert W. Baird upped their price target on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Leerink Partnrs upgraded Envista from a “strong sell” rating to a “hold” rating in a report on Thursday, October 31st. Evercore ISI boosted their price objective on Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Finally, Piper Sandler lifted their price target on Envista from $16.00 to $17.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $20.65.

Envista Trading Down 5.4 %

Shares of NVST opened at $18.20 on Thursday. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The firm has a 50-day moving average price of $20.12 and a 200 day moving average price of $18.44. Envista Holdings Co. has a 12-month low of $15.15 and a 12-month high of $25.64. The firm has a market capitalization of $3.13 billion, a P/E ratio of -2.34, a P/E/G ratio of 2.71 and a beta of 1.31.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.09 by $0.03. The firm had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.43 EPS. Sell-side analysts forecast that Envista Holdings Co. will post 0.72 EPS for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.